We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Releasing the Handbrake on Endogenous Repair – An Alternative Approach to Treating Alzheimer’s Disease?
Blog

Technology Networks recently spoke with Paul Brennan, President and CEO at NervGen Pharma, to gain his insights on why previous attempts to treat Alzheimer's disease have failed, how the novel technology platform NVG-291 works and what promise it holds for AD.

Read More

Motion Capture Trends in Biomechanical Science
Blog

In this article, we discuss current examples of how motion capture technology can be applied across the life sciences industry.

Read More

Tackling Immune Dysregulation – A Key Driver of Disease
Blog

Immune dysregulation plays a central role in many pathologies. We spoke with Dr Fabienne Charrier-Savournin, from Cisbio, to learn more about the mechanisms underpinning immune dysregulation and how this knowledge is applied for therapeutic intervention.

Read More

Thermo Fisher Scientific Joins the Pistoia Alliance
Blog

Recently, Thermo Fisher Scientific announced its membership of the Pistoia Alliance. At the Lab of the Future Congress 2019, we spoke with members of the Thermo Fisher team to learn more about the goals of joining the alliance, and what innovation means to Thermo Fisher.

Read More

Celebrations All Round for Analysis Veterans
Blog

As a stalwart in the biological and chemical analysis fields, JEOL celebrates its 70th anniversary this year. But that’s not all it is celebrating, with the appointment of 35-year veteran of JEOL USA, Bob Pohorenec as President of the company this year.

Read More

How a Female Executive Became a Leader in the Business of Science
Blog

Trisha Rice, VP & GM Materials Science Business at Thermo Fisher Scientific, shares her experiences as a woman in science, and provides tips on how to be your most "authentic self" in the field.

Read More

Fuelling Innovation in UK Life Sciences
Blog

We spoke to Daniel Rooke, Head of Operations and Legal at Start Codon, to learn more about the company and how they can help early stage healthcare and life science businesses in the UK to get off the ground.

Read More

Therapeutically Targeting the Interconnected Biology of the Gut
Blog

We recently had the pleasure of interviewing Paul-Peter Tak, CEO of Kintai Therapeutics. Tak discusses how Kintai Therapeutics are exploiting the power of big data and machine learning to unravel the interconnected biology of the gut, and explains how the enteric signaling network can be therapeutically targeted.

Read More

Fighting Neurodegeneration by Understanding Inflammation
Blog

Neurodegenerative diseases are one of the most pressing challenges of our time and teasing out the cellular mechanisms underpinning these diseases is a key goal for researchers in the field. We talked to Stéphane Martinez of CISBIO to discuss how researchers can access information on neurodegenerative mechanisms and how we are beginning to recognize the contribution of the immune system to neurodegeneration.

Read More

Targeting Tau Pathology to Slow Alzheimer’s Disease Progression
Blog

To learn more about AC Immune's series of compounds designed to target tau aggregation, we recently spoke with Prof. Andrea Pfeifer, the company's Chief Executive Officer.

Read More